Home › Department of Health and Human Services › Contract 75A50119C00055
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
Federal contract 75A50119C00055 with Department of Health and Human Services, currently held by ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE).
Expires 2027-09-30 · in 13 months
- Incumbent
- ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Industry (NAICS)
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Ceiling value
- $147,062,009
- Period of performance
- 2019-09-26 to 2027-09-30
- Award ID
- 75A50119C00055
Contract description
THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.
Recompete context. This contract's current period of performance ends on
2027-09-30 (in 13 months). When a period of performance ends, the
agency typically either recompetes the work, extends the incumbent, or exercises a remaining option.
An end date is the earliest reliable public signal that a follow-on may be coming, which is why capture
teams track it. It is not a guarantee of a recompete. All figures are drawn from
USAspending.gov (U.S. Treasury) and are public domain.
Other Department of Health and Human Services contracts on the cliff
| Incumbent | Ceiling value | Ends | Expiry |
|---|---|---|---|
| NOVITAS SOLUTIONS, INC. | $921,080,482 | 2026-08-31 | expiring now |
| VERIZON BUSINESS NETWORK SERVICES LLC | $406,353,536 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $371,787,375 | 2026-08-30 | expiring now |
| LEIDOS, INC. | $152,046,866 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $87,806,507 | 2026-08-30 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $80,917,684 | 2026-08-31 | expiring now |